Gal Maier

1.9k total citations
5 papers, 713 citations indexed

About

Gal Maier is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gal Maier has authored 5 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Cancer Research and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gal Maier's work include Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Gal Maier is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Gal Maier collaborates with scholars based in United Kingdom. Gal Maier's co-authors include Johann S. de Bono, Gerhardt Attard, David Olmos, Emilda Thompson, Elizabeth Folkerd, Thian Kheoh, Mitch Dowsett, Arturo Molina, David P. Dearnaley and Alison Reid and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Gal Maier

5 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gal Maier United Kingdom	3	659	235	229	204	142	5	713
Emilda Thompson United Kingdom	4	658 1.0×	223 0.9×	164 0.7×	292 1.4×	178 1.3×	7	766
Ellen S. de Morrée Netherlands	8	394 0.6×	179 0.8×	173 0.8×	69 0.3×	154 1.1×	10	544
Nikhil Babu Oommen United Kingdom	6	904 1.4×	366 1.6×	212 0.9×	383 1.9×	255 1.8×	7	1.1k
Mari Nakazawa United States	10	836 1.3×	434 1.8×	192 0.8×	149 0.7×	334 2.4×	25	1.0k
Katherine Sunderland Canada	10	694 1.1×	331 1.4×	190 0.8×	75 0.4×	161 1.1×	23	761
E. Ileana France	5	314 0.5×	125 0.5×	151 0.7×	82 0.4×	58 0.4×	8	359
Oliver Sartor United States	10	346 0.5×	98 0.4×	64 0.3×	120 0.6×	97 0.7×	22	437
Nicholas I. Simon United States	11	521 0.8×	253 1.1×	75 0.3×	178 0.9×	240 1.7×	31	720
Shivang Doshi United States	4	406 0.6×	197 0.8×	59 0.3×	117 0.6×	184 1.3×	5	528
Reetta Riikonen Finland	6	283 0.4×	110 0.5×	86 0.4×	106 0.5×	153 1.1×	19	433

Countries citing papers authored by Gal Maier

Since Specialization

Citations

This map shows the geographic impact of Gal Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Maier more than expected).

Fields of papers citing papers by Gal Maier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Maier. The network helps show where Gal Maier may publish in the future.

Co-authorship network of co-authors of Gal Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Gal Maier. A scholar is included among the top collaborators of Gal Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gal Maier. Gal Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Omlin, Aurelius, Carmel Pezaro, Deborah Mukherji, et al.. (2013). Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms. European Urology. 64(2). 300–306. 69 indexed citations

2.

Pezaro, Carmel, Diletta Bianchini, Andrea Zivi, et al.. (2012). Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?. Annals of Oncology. 23(11). 2943–2947. 194 indexed citations

3.

Pezaro, Carmel, Aurelius Omlin, Deborah Mukherji, et al.. (2012). Survival in metastatic castration resistant prostate cancer (mCRPC) trial participants.. Journal of Clinical Oncology. 30(15_suppl). e15136–e15136. 1 indexed citations

4.

Folkerd, Elizabeth, G. Attard, David P. Dearnaley, et al.. (2009). Abiraterone acetate: the novel application of a CYP450c17 inhibitor to the treatment of both prostate and breast cancer. 19. 1 indexed citations

5.

Attard, Gerhardt, Alison Reid, Roger A’Hern, et al.. (2009). Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 27(23). 3742–3748. 448 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact